Vancomycin-resistant Enterococcus infections in solid organ transplantation (Q42272348)

19 October 2017

Vancomycin-resistant Enterococcus infections in solid organ transplantation (English)

1 reference

AST Infectious Diseases Community of Practice

19 October 2017

organ transplantation

1 reference

1 reference

series ordinal

3

object named as

AST Infectious Diseases Community of Practice

1 reference

19 October 2017

G Patel

1

1 reference

PubMed ID

23464999

19 October 2017

D R Snydman

series ordinal

2

1 reference

PubMed ID

23464999

19 October 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

American Journal of Transplantation

19 October 2017

1 reference

19 October 2017

13 Suppl 4

1 reference

19 October 2017

59-67

1 reference

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

19 October 2017

1 reference

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis

21 January 2018

1 reference

Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.

21 January 2018

1 reference

The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units

21 January 2018

1 reference

Antianaerobic Antibiotic Therapy Promotes Overgrowth of Antibiotic-Resistant, Gram-Negative Bacilli and Vancomycin-Resistant Enterococci in the Stool of Colonized Patients

21 January 2018

1 reference

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

21 January 2018

1 reference

Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

21 January 2018

1 reference

Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens

21 January 2018

1 reference

Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci

21 January 2018

1 reference

Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci

21 January 2018

1 reference

Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit

21 January 2018

1 reference

Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns

21 January 2018

1 reference

Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

21 January 2018

1 reference

Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.

21 January 2018

1 reference

Vancomycin-resistant Enterococcus in liver transplant patients

21 January 2018

1 reference

An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients.

21 January 2018

1 reference

Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients

21 January 2018

1 reference

Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients

21 January 2018

1 reference

Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients

21 January 2018

1 reference

Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.

21 January 2018

1 reference

Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients

21 January 2018

1 reference

Low prevalence of colonization with vancomycin-resistant Enterococcus in patients awaiting liver transplantation

21 January 2018

1 reference

Single center experience of a vancomycin resistant enterococcal endocarditis cohort

21 January 2018

1 reference

Left ventricular assist device-related infection: treatment and outcome.

21 January 2018

1 reference

Infective endocarditis in solid organ transplant recipients.

21 January 2018

1 reference

Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.

21 January 2018

1 reference

Epidemiology of bacteriuria caused by vancomycin-resistant enterococci--a retrospective study.

21 January 2018

1 reference

Vancomycin resistance in gram-positive cocci

21 January 2018

1 reference

Emergence and management of drug-resistant enterococcal infections

21 January 2018

1 reference

Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex

21 January 2018

1 reference

Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

21 January 2018

1 reference

Recommendations for preventing the spread of vancomycin resistance

21 January 2018

1 reference

Comparison of performance of the novel chromogenic spectra VRE agar to that of bile esculin azide and Campylobacter agars for detection of vancomycin-resistant enterococci in fecal samples

21 January 2018

1 reference

Evaluation of a chromogenic agar under development to screen for VRE colonization

21 January 2018

1 reference

Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis isolates

21 January 2018

1 reference

A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.

21 January 2018

1 reference

Evaluation of Spectra VRE, a new chromogenic agar medium designed to screen for vancomycin-resistant Enterococcus faecalis and Enterococcus faecium

21 January 2018

1 reference

Evaluation of PCR-based screening for vancomycin-resistant enterococci compared with a chromogenic agar-based culture method.

21 January 2018

1 reference

Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy

21 January 2018

1 reference

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

21 January 2018

1 reference

Enterococcal intravascular catheter-related bloodstream infection: management and outcome of 61 consecutive cases

21 January 2018

1 reference

The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus.

21 January 2018

1 reference

Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections.

21 January 2018

1 reference

Emergence of resistance to chloramphenicol among vancomycin-resistant enterococcal (VRE) bloodstream isolates

21 January 2018

1 reference

Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin

21 January 2018

1 reference

Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.

21 January 2018

1 reference

Risk factors for arthralgias or myalgias associated with quinupristin-dalfopristin therapy

21 January 2018

1 reference

Arthralgias and myalgias related to quinupristin-dalfopristin administration

21 January 2018

1 reference

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

21 January 2018

1 reference

Linezolid in the treatment of vancomycin‐resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate‐use trial

21 January 2018

1 reference

Peripheral neuropathy associated with prolonged use of linezolid

21 January 2018

1 reference

Linezolid-associated toxic optic neuropathy: a report of 2 cases

21 January 2018

1 reference

Linezolid-associated peripheral and optic neuropathy in children

21 January 2018

1 reference

Linezolid-induced optic neuropathy

21 January 2018

1 reference

Serotonin toxicity associated with the use of linezolid: a review of postmarketing data

21 January 2018

1 reference

Linezolid-induced lactic acidosis

21 January 2018

1 reference

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

21 January 2018

1 reference

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.

21 January 2018

1 reference

Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients

21 January 2018

1 reference

Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.

21 January 2018

1 reference

Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations

21 January 2018

1 reference

Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection

21 January 2018

1 reference

Emergence of daptomycin-resistant VRE: experience of a single institution

21 January 2018

1 reference

Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians

21 January 2018

1 reference

Tigecycline: a new glycylcycline for treatment of serious infections

21 January 2018

1 reference

Peritoneal fluid penetration of tigecycline

21 January 2018

1 reference

Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms

21 January 2018

1 reference

Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States

21 January 2018

1 reference

Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections.

21 January 2018

1 reference

Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).

21 January 2018

1 reference

In-vitro activity of fosfomycin against vancomycin-resistant enterococci

21 January 2018

1 reference

In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin

21 January 2018

1 reference

Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin

21 January 2018

1 reference

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).

21 January 2018

1 reference

Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease

21 January 2018

1 reference

Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

21 January 2018

1 reference

The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients

21 January 2018

1 reference

Vancomycin-resistant enterococci: why are they here, and where do they come from?

21 January 2018

1 reference

Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment.

21 January 2018

1 reference

Transfer of vancomycin-resistant enterococci via health care worker hands

21 January 2018

1 reference

Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci

21 January 2018

1 reference

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.

21 January 2018

1 reference

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus

21 January 2018

1 reference

The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis

21 January 2018

1 reference

Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports

21 January 2018

1 reference

Excess deaths associated with tigecycline after approval based on noninferiority trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/AJT.12099

1 reference

19 October 2017

1 reference

PubMed ID

23464999